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Inhalation Pharmacokinetics of Isoprene
in Rats and Mice
by Hans Peter,* Hans-Jurgen Wiegand,* Johannes
G. Filser,t Hermann M. Bolt,* and Reinhold J. Laib*
Studies on inhalation pharmacokinetics ofisoprene wereconducted in rats (Wistar) and mice (B6C3FN)to
investigate possible species differences in metabolism of this compound. Pharmacokinetic analysis of
isoprene inhaled by rats and mice revealed saturation kinetics ofisoprene metabolism in both species. For
rats and mice, linear pharmacokinetics apply at exposure concentrations below 300 ppm isoprene. Satu-
ration of isoprene metabolism is practically complete at atmospheric concentrations ofabout 1000 ppm in
rats and about 2000 ppm in mice. In the lower concentration range where first-order metabolism applies,
metabolic clearance (related to the concentration in the atmosphere) ofinhaled isoprene per kilogram body
weight was 6200 mL/hr for rats and 12,000 mL/hr for mice. The estimated maximal metabolic elimination
rates were 130 ,umole/hrfkg for rats and 400 pmole/hr/kg for mice. This shows that the rate of isoprene
metabolism in mice is about two or three times that in rats.
Whentheuntreated animals are kept in aclosed all-glassexposure system, the exhalation ofisoprene into
the system can be measured. This shows that the isoprene endogenously produced by the animals is
systemically availablewithinthe animal organism. From such experiments theendogenous productionrate
ofisoprene wascalculated tobe 1.9 ,umole/hr/kgforratsand0.4 ,mole/hr/kgformice. Ourdataindicatethat
the endogenous production ofisoprene should be accounted for when discussing a possible carcinogenic or
mutagenic risk of this compound.
Introduction
Isoprene (2-methyl-1,3-butadiene) isused extensively
in the manufacture of synthetic elastomers and pre-
dominantly in the production ofcis-1,4-polyisoprene (2).
Isoprene is structurally related to 1,3-butadiene, a ma-
jor component in synthetic rubber, which has been
shown to be carcinogenic in mice (3) and rats (4) and
genotoxic in mice (5).
In liver microsomal incubations ofmouse, rat, rabbit,
andhamster(6,7)isopreneismetabolized bycytochrome
P-450 enzymes to the corresponding monoepoxides
3,4-epoxy-3-methyl-1-butene (half-life 75 min) and 3,4-
epoxy-2-methyl-1-butene (half-life 73 hr) at a ratio of
about 4:1. When added to mouse liver microsomal incu-
bations (6) the minor epoxide metabolite 3,4-epoxy-
2-methyl-1-butene was further oxidized to isoprene di-
oxide (2-methyl-1,2,3,4-diepoxybutane).
In contrast to butadiene (8), isoprene or its mono-
epoxides were notmutagenic inS. t?yphimurium, either
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in the presence or absence of rat liver S9 (9). Isoprene
diepoxide (2-methyl-1,2,3,4-diepoxybutane), however,
appears tobe as potent a mutagen inS. typhimurium as
diepoxybutane (9). Furthermore, cytogenetic damage
could be observed in B6C3F1 mice after exposure ofthe
animals to isoprene (10). In addition, 2-methyl-
1,2,3,4-diepoxybutane could be characterized by vac-
uum line cryogenic distillation in the blood and other
tissues of rats after exposure of the animals to 14C-
isoprene (11).
The purpose of our studies was to provide compara-
tive pharmacokinetic data on the metabolism ofinhaled
isoprene in rats and mice, as previously obtained for
1,3-butadiene (12). Therefore, comparative studies in
rats (Wistar) and mice (B6C3F1) on inhalation pharma-
cokinetics of isoprene have been conducted. Further-
more, exhalation by untreated animals ofendogenously
formed isoprene was measured, and the rate of endo-
genous production of this compound was calculated for
both species.
Methods
The methodological details of this investigation have
alreadybeenpublished (13). Thus, only abriefsummary
is given here ofthe methods used. [See also Laib et al.
(12).]
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FIGURE 1. The top line ofeach graph refers to the time course ofisoprene concentrations in the gas phase ofa closed 6.4 L desiccatorjar chamber
occupied bytwo Wistarrats (left) orfive B6C3F1 mice (right). Individual experiments with differentinitialisoprene concentrations between 5
and 5000 ppm. The bottom line ofeach graph refers to the time course ofisoprene concentrations exhaled by untreated animals into the gas
phase of the closed exposure system (6.4 L) occupied by two Wistar rats (left) or five B6C3Fj mice (right).
(25-30 g) were used in these experiments. Usually two
rats orfive mice were placed in aclosed 6.4 L desiccator
jar chamber, equipped with 135 g soda lime for CO2
absorption and an oxygen supply (12). Theanimals were
exposed to initial concentrations between about 5 ppm
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and 5000 ppm isoprene. Initial concentrations were ad-
justed by either injecting agaseous mixture ofisoprene
with air (5-1000 ppm) or by direct injection ofthe vola-
tile liquid (1000 ppm) into the closed exposure system.
Concentrationchanges ofthecompoundinthegasphase
of the system were measured by gas chromatography
(Fig. 1, top). Similarly, exhalation and accumulation of
isoprene endogenously produced by untreated animals,
while in the closed exposure system was determined
(Fig. 1, bottom).
Kinetic parameters were determined from the con-
centration time-courses thus obtained, based on a two-
compartment, pharmacokineticmodeldeveloped by Fil-
serandBolt(14,15). Thegasphaseinthedesiccatorwith
volume V1 represented compartment 1 (Cpl), the ani-
mals with volume V2 represented compartment 2 (Cp2)
[see model in Laib et al. (12)]. The full details of the
analytical procedures and the pharmacokinetic analysis
have been presented elsewhere (13-15).
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FIGURE 2. Metabolic elimination rates ofB6C3F1 mice (0) and Wistar
rats (0) depending on atmospheric concentrations of isoprene.
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Startingfrom differentinitialconcentrations between
5 and 5000 ppm, the time-dependent decline ofisoprene
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in the exposure system, occupied by rats or mice, was
investigated (13). The five decline curves observed in
these experiments for rats or mice (Fig. 1, top) become
flatter at higher exposure concentrations, indicating
saturable metabolism ofisoprene in both species. Below
concentrations ofabout300 ppmisoprene, metabolismis
proportional to the atmospheric concentration of the
substance, and the elimination of isoprene by rats or
mice canbedescribedby afirst-order process. Athigher
atmospheric concentrations saturation kinetics become
apparentinbothspecies. Saturation ofisoprene metabo-
lism is practically complete at atmospheric concentra-
tions ofabout 1500 ppm in rats and at about 2000 ppm in
mice. Athigherconcentrations theincrease is negligible
in the metabolic rate of isoprene observed for both
species.
The pharmacokinetic parameters for distribution and
metabolism of isoprene were determined from the
concentration-decline curves obtained (14,15) (Table 1).
They show, inprinciple, thatthe rate ofisoprene metab-
olism in mice is about two to three times that in rats. In
the lowerconcentration range, where first-ordermetab-
olism applies, metabolic clearance per kg body weight
was 12,000 mL/hrformice and 6,200mL/hrforrats. The
estimated maximalmetabolic elimination rates were400
,umole/hr/kg for mice and 130 ,umole/hr/kg for rats.
Accumulation of isoprene in the organism is deter-
mined by the rates ofuptake via inhalation, exhalation,
and metabolism. Isoprene accumulates in the organism
as long as the rates of inhalation exceed the rates of
exhalation and metabolism. At high concentrations,
when metabolizing enzymes are saturated, accumu-
lation is determined only by the rates of inhalation and
exhalation, whereas metabolism becomes negligible. At
such conditions accumulation is determined by the
thermodynamic partition coefficient that represents the
concentration equilibrium betweenthe animal organism
and the atmosphere (14). Accumulation of isoprene is
very similar in both species investigated (7.8 times in
rats and 7.0times inmice) and is related to the solubility
of isoprene in the tissues of the animals. A similar
thermodynamic partition coefficient for isoprene of
about 7.9 can be estimated by means of the Ostwald
partition coefficients of isoprene for olive oil/air, and
saline/air, respectively (16).
In the lower concentration range where first-order
metabolism applies (< 300 ppm), the concentration
ratios of isoprene between the animal organism and
atmosphere aremuch lowerthancouldbeexpected from
the partition coefficients. In this concentration range
only limited accumulation is observed, and metabolic
clearance in both species is similar to the clearance of
uptake of isoprene from the gas phase. This indicates
that the overwhelming part of isoprene entering the
animal organism is metabolized. A comparison of the
clearancesofuptake(V1k12) andtheclearancesofmetab-
olism (V2Kstke,) reveals, that only a minor part (about
15% in rats and about 25% in mice) ofisoprene taken up
by the animals is exhaled unchanged.
Figure 2 shows the metabolic elimination curves of
isoprene for rats and mice, calculated for conditions of
exposure in an open (V1 > c) exposure system (14).
Up to ambient concentrations of about 300 ppm iso-
prene, the metabolic elimination of isoprene is pro-
portional tothe exposure concentration inmice and rats.
Above about 1000 ppm in rats and 2000 ppm in mice,
saturation of isoprene metabolism is practically com-
plete. A comparison ofthemetabolic elimination rates of
both species at different exposure concentrations re-
veals that the metabolic elimination rate ofisoprene in
Table 1. Pharmacokinetic parameters for distribution and metabolism of isoprene (2-methyl-1,3-butadiene) in mice (B6C3F1) and rats
(Wistar) related to 1 kg body weight. [For definition of parameters see text and references (13,14)].a
Parameter Ratsb Miceb Dimension
Thermodynamic partition coefficient 7.8 ± 3 7.0 ± 2 nL gas/mL tissue
(whole body/air); KeqC ppm in atmosphere
Concentration ratio in steady statec 1.2 ± 0.4 1.7 ± 0.6 nL gas/mL tissue
(whole body/air); K8t ppm in atmosphere
Clearance ofuptake from the
atmosphere (related to the
concentration in the atmosphere);
Vjkl2c 7,300 ± 2,000 16,000 ± 3,000 mL/hr
Clearance ofmetabolism' (related to
the concentration in the atmosphere);
V2Kstkeic 6,200 ± 1,000 12,000 + 3,000 mL/hr
Clearance of exhalation (related to the
concentration in the body); V2k21C 940 ± 300 2,300 + 1,000 mL/hr
Half lifed; ln2/(kel + k2l)c 6.8 ± 2.4 4.4 ± 1.5 min
Maximal rate ofmetabolism; (Vmax)C 130 (Fig. 2) 400 (Fig. 2) ,umole/hr/kg
Endogenous production ratee; dNpr/dtc 1.9 ± 0.8 0.4 ± 0.2 ,umole/hr/kg
Rate ofmetabolism ofendogenously
produced isoprenee 1.6 ± 0.7 0.3 ± 0.2 ,umole/hr/kg
aCalculations for: 1 kg body weight (V2 = 1000 mL); dynamic (open) exposure system [(V1 > 00; according to Filser and Bolt (14,15)].
bMean value ± SD of three exposures with two rats, five mice, each.
cCalculated for the systemically available isoprene.
dPharmacokinetic constants calculated according to the two-compartment model (14,15).
eBetween 50 and 250 ppm (rat) and between 10 and 300 ppm (mouse).
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Table 2. Species differences in exhalation of isoprene
endogenously produced.
Rate of exhalation, Amount exhaled/24 hr
Species ,umole/hr/kg (per individual)
Rat, 200g 0.3 0.1mg
Mouse, 30 g 0.1 0.005 mg
Man, 75 kga 0.015-0.03 2-4 mg
aData calculated from Gelmont et al. (1).
mice is about two to three times that in rats, depending
on the exposure concentrations applied.
Exhalation of Isoprene by Untreated
Animals
When untreated rats or mice are kept in the closed
exposure system, exhalation ofisoprene into the air of
the system can be measured. Figure 1 (bottom curve)
shows, that after an initial increase, isoprene exhaled
reaches aplateauconcentration ofabout0.8ppmforrats
and about 0.2 ppm for mice. This shows that isoprene is
endogenously produced by the aninmals and it is sys-
temically available within the animal organism. From
this experiment, the rate of endogenous production of
isoprene can be calculated as 1.9 ,umole/hr/kg for rats
and 0.4 ,umole/hr/kg for mice. Under these particular
conditionsthemetabolicrateforendogenouslyproduced
isoprene isestimated tobeabout 1.6 ,umole/hr/kginrats
and 0.3 ,umole/hr/kg in mice.
The rate ofproduction ofendogenous isoprene in rats
and mice exceeds that ofn-pentane or ethane by two to
threeordersofmagnitude (17). Isopreneisalsothemain
hydrocarbon in human breath (1,18) and is exhaled by
human subjects in amounts of 2 to 4 mg per day. A
species comparison ofthe rates ofexhalation ofendoge-
nously produced isoprene reveals that the exhalation
rate of isoprene by man (related to kilogram body
weight) is about one order of magnitude lower when
compared to mouse or rat (Table 2).
Recent data on cytogenetic activity ofisoprene in the
bone marrow cells of B6C3F1 mice [significantly ele-
vated frequencies ofsisterchromatid exchange and mic-
ronuclear polychromatic erythrocytes after exposure of
the animals to isoprene (19)] and similar toxicologic
effects as previously observed for 1,3-butadiene in an
ongoing inhalation exposure study with B6C3F1 mice
suggest thatisoprene may have acarcinogenic potential
in this species (20). Furthermore, isoprene-diepoxide
was characterized inbloodand othertissuesofrats after
exposure ofthe animals to14C-isoprene (11). These data
stress the need for interstrain comparative studies on
the metabolism and disposition of isoprene in rodents
and man. Finally, our results indicate that the endoge-
nousproductionofisoprene shouldbetakeninto account
when discussing a possible carcinogenic or mutagenic
risk of this compound.
The authors thank W. Zolffel and S. Deutsch for typing the
manuscript.
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